Does RIFAXIMIN Cause Disease recurrence? 126 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Disease recurrence have been filed in association with RIFAXIMIN (XIFAXAN). This represents 0.9% of all adverse event reports for RIFAXIMIN.
126
Reports of Disease recurrence with RIFAXIMIN
0.9%
of all RIFAXIMIN reports
4
Deaths
41
Hospitalizations
How Dangerous Is Disease recurrence From RIFAXIMIN?
Of the 126 reports, 4 (3.2%) resulted in death, 41 (32.5%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAXIMIN. However, 126 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which RIFAXIMIN Alternatives Have Lower Disease recurrence Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB